Dunhill Financial’s Bio-Techne TECH Stock Holding History

Dunhill Financial’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$838	Buy	11 +6	+120%	+$324	﹤0.01%	1037
2026 Q1	$307	Sell	5 -3	-38%	-$180	﹤0.01%	1184
2025 Q4	$476	Buy	8 +5	+167%	+$304	﹤0.01%	940
2025 Q3	$182	Sell	3 -2	-40%	-$107	﹤0.01%	935
2025 Q2	$263	Sell	5 -27	-84%	-$1.36K	﹤0.01%	925
2025 Q1	$1.89K	Sell	32 -3	-9%	-$203	﹤0.01%	744
2024 Q4	$2.55K	Buy	35 +7	+25%	+$514	﹤0.01%	676
2024 Q3	$2.23K	Buy	28 +14	+100%	+$1.05K	﹤0.01%	696
2024 Q2	$1.02K	Buy	14 +2	+17%	+$147	﹤0.01%	687
2024 Q1	$819	Buy	12 +2	+20%	+$143	﹤0.01%	667
2023 Q4	$755	Buy	+10	New	+$659	﹤0.01%	647

Other funds holding TECH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Dunhill Financial's TECH Position: Q2 2026 in Review

Dunhill Financial increased its Bio-Techne (TECH) stake by 120% in Q2 2026, buying an estimated $324 and bringing the position to 11 shares worth $838. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Dunhill Financial first reported a position in TECH in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.55K in Q4 2024. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

Dunhill Financial held 11 shares of Bio-Techne worth $838 as of Q2 2026.
Dunhill Financial bought 6 Bio-Techne shares in Q2 2026, an estimated $324.
Bio-Techne made up ﹤0.01% of Dunhill Financial's portfolio in Q2 2026, its #1037 holding.
Dunhill Financial first reported a position in Bio-Techne in Q4 2023 and has held it in 11 quarters since.
Dunhill Financial's Bio-Techne position peaked at $2.55K in Q4 2024.
593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Dunhill Financial's 13F filing for Q2 2026, filed 7 Aug 2026.